The effect of vitamin D supplementation on adiposity, blood glycated hemoglobin, serum leptin and tumor necrosis factor-α in type 2 diabetic patients

International Journal of Preventive Medicine

Volumn 5, Issue 9, 2014, Pages 1091-1098

  Ghavamzadeh, Saeid ^a   Mobasseri, Majid ^b   Mahdavi, Reza ^c  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiposity; Leptin; Supplemental vitamin D3; Tumor necrosis factor ; Type 2 diabetes

Indexed keywords

COLECALCIFEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; LEPTIN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 84907170171     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alfonso B, Liao E, Busta A, Poretsky L. Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment. Diabetes Metab Res Rev 2009;25:417-9.
2. Kamycheva E, Joakimsen RM, Jorde R. Intakes of calcium and vitamin d predict body mass index in the population of Northern Norway. J Nutr 2003;133:102-6.
3. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: A population-based study in older men and women. J Clin Endocrinol Metab 2005;90:4119-23.
4. Penckofer S, Kouba J, Wallis DE, Emanuele MA. Vitamin D and diabetes: Let the sunshine in. Diabetes Educ 2008;34:939-40, 942, 944.
5. Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:185-97.
6. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 2005;48:1038-50.
7. Peraldi P, Spiegelman B. TNF-alpha and insulin resistance: Summary and future prospects. Mol Cell Biochem 1998;182:169-75.
8. Lemire JM. Immunomodulatory actions of 1, 25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1995;53:599-602.
9. Mauricio D, Mandrup-Poulsen T, Nerup J. Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: A therapeutic perspective. Diabetes Metab Rev 1996;12:57-68.
10. Bloomgarden ZT. American Diabetes Association Annual Meeting, 1998. Treatment of type 2 diabetes. Diabetes Care 1999;22:170-4.
11. Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001;50 Suppl 1:S118-21.
12. Gariano RF, Nath AK, D’Amico DJ, Lee T, Sierra-Honigmann MR. Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci 2000;41:3576-81.
13. Uckaya G, Ozata M, Bayraktar Z, Erten V, Bingol N, Ozdemir IC. Is leptin associated with diabetic retinopathy? Diabetes Care 2000;23:371-6.
14. ® Leptin (Sandwich) ELISA (EIA-2395). Available from: http://www.drg-international.com/ifu/eia-2395.pdf
15. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003;88:157-61.
16. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004;89:1196-9.
17. Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: Relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008;57:183-91.
18. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008;7:4.
19. Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010;2010:351385.
20. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009;26:19-27.
21. Arabi A, Baddoura R, Awada H, Salamoun M, Ayoub G, El-Hajj Fuleihan G. Hypovitaminosis D osteopathy: Is it mediated through PTH, lean mass, or is it a direct effect? Bone 2006;39:268-75.
22. Moyad MA. Osteoporosis. Part III–Not just for bone loss: Potential benefits of calcium and vitamin D for overall general health. Urol Nurs 2003;23:69-74.
23. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sørensen OH, et al. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance–A prospective randomized double-blind study. Acta Med Scand 1987;222:361-7.
24. Kositsawat J, Freeman VL, Gerber BS, Geraci S. Association of A1C levels with vitamin D status in U.S. adults: Data from the National Health and Nutrition Examination Survey. Diabetes Care 2010;33:1236-8.
25. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006;29:722-4.
26. Schwalfenberg G. Vitamin D and diabetes: Improvement of glycemic control with vitamin D3 repletion. Can Fam Physician 2008;54:864-6.
27. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 2009;48:349-54.
28. Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in type 2 diabetes: A pilot prospective randomized trial. J Diabetes 2010;2:36-40.
29. Guerre-Millo M. Adipose tissue and adipokines: For better or worse. Diabetes Metab 2004;30:13-9.
30. Sharma R, Sharma CL. TNF-alpha inhibitors: Current indications. Indian J Crit Care Med 2007;11:139-48.
31. Sfikakis PP, Markomichelakis N, Theodossiadis GP, Grigoropoulos V, Katsilambros N, Theodossiadis PG. Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab. Diabetes Care 2005;28:445-7.
32. Menendez C, Lage M, Peino R, Baldelli R, Concheiro P, Diéguez C, et al. Retinoic acid and vitamin D (3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol 2001;170:425-31.
33. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol 2005;97:93-101.
34. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009;94:4023-30.
35. Hedbacker K, Birsoy K, Wysocki RW, Asilmaz E, Ahima RS, Farooqi IS, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 2010;11:11-22.